As of Jan 20
| +0.54 / +5.00%|
The 5 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 20.00, with a high estimate of 23.00 and a low estimate of 12.00. The median estimate represents a +76.52% increase from the last price of 11.33.
The current consensus among 5 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.